ABSTRACT -We used DNA microarrays to monitor the transcriptional responses of IMR-32 neuroblastoma cells to methylmercury. Methylmercury increased levels of expression of seven genes, including genes for ETV5 and ID4, and reduced those of two genes.
INTRODUCTION
Methylmercury is an environmental pollutant that damages the central nervous system, and many cases of methylmercury poisoning have been reported (Castoldi et al., 2003) . However, little is known about the molecular mechanism of methylmercury poisoning. We postulated that treatment of neuroblastoma cells with methylmercury would induce various intracellular reactions and, in particular, changes in the levels of expression of certain genes. To examine our hypothesis, we examined levels of transcripts in IMR-32 cells before and after treatment for 6 and 24 hr with methylmercury using DNA microarrays.
MATERIALS AND METHODS

Exposure of cells to methylmercury
IMR-32 human neuroblastoma cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 IU/ml penicillin and 100 mg/ml streptomycin. Cultures were maintained at 37°C in a humidified atmosphere of 10% CO 2 in air. IMR-32 cells (1 × 10 6 cells) were distributed in six-well plates and cultured in 1-ml aliquots of medium. After incubation for 24 hr, 1 μM methymercury chloride was added to the medium and cells were cultured for 6 hr, during which the cell-survival rate was close to 100%, and for 24 hr, during which fewer than 10% of cells ceased to be viable.
Eextraction of RNA
Control IMR-32 cells and cells that had been treated with methylmercury chloride were lysed with TRIzol (Life Technologies Inc., Rockville, MD, USA) according to the manufacturer's protocol and total RNA was extracted by the standard method and stored at −80°C.
Microarray analysis
Purified RNA (8 μg) was reverse transcribed by Superscript II reverse transcriptase (Life Technologies Inc.) with T7-(dT) 24 , which contains a promoter recognized by T7 RNA polymerase, as primer. Then complementary DNA (cDNA) was synthesized and used as template for transcription in vitro of biotinylated complementary RNA (cRNA). Fifteen micrograms of fragmented cRNA were allowed to hybridize to an HGFocus microarray (Affymetrix, Santa Clara, CA, USA) for 16 hr at 45°C with constant rotation at 60 rpm according to the protocol from Affymetrix. This highdensity oligonucleotide-based array is specific for approximately 8,500 human genes selected from the Gene Bank database of the National Center for Biotechnology Information (NCBI, USA). A separate microarray was used for the analysis of each individual sample. After hybridization, the microarray was washed and stained on an Affymetrix Fluidics Station and scanned with a confocal argon laser, with emission of 488 nm and detection at 570 nm. Data were analyzed with Genespring software, version 7.0 (Silicon Genetics, San Carlos, CA, USA).
RESULTS AND DISCUSSION
We used DNA microarrays to identify for genes whose levels of expression chaged when IMR-32 cells were treated with methylmercury (1 μM) for 6 hr (cell viability rate, approximately 100%) and 24 hr (cell viability rate, greater than 90%). We found that treatment for 6 hr and for 24 hr more than doubled the levels of expression of seven genes and more than halved those of two genes (Table 1) . Among the first set of genes, the gene for CDKN1A has already been identified as a gene whose level of expression increases when cells from rat embryonic limb buds and the midbrain central nervous system are treated with methylmercury (Ou et al., 1999) . However, to our knowledge, the remaining eight genes that we identified have not previously been reported to be associated with exposure of cells to methylmercury. Our findings provide useful clues to the nature of the response of neural cells to methylmercury. Tumor progression 0.3 0.5 NM_022443 MLF1 IMR-32 cells were treated with methylmercury for 6 hr and 24 hr, and then gene expression was analyzed with DNA microarrays. The genes presented in the Table include only those whose levels of expression changed (with an increase of more than two-fold or a decrease of more than 50%) not only when IMR-32 cells were treated with methylmercury for 6 hr but also when they were treated for 24 hr.
